Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Morgan

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Dermatology|June 28, 2025
Are Skin Lesion Superclinics Associated With Decision Fatigue? A Controlled, Observational StudyHuw W S Greenish, Hafsa Faarax Shirwac, Hannah Morgan, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
The Role Of Drug Indication On Incidence Rate Heterogeneity: A Large-Scale, Systematic Evaluation Across An International Network Of Observational DatabasesHsin Yi Chen, Christopher Knoll, Elise Boventer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2024
Treatment of Multidrug-resistant or Rifampicin-resistant Tuberculosis With an All-oral 9-month Regimen Containing Linezolid or Ethionamide in South Africa: A Retrospective Cohort StudyHannah Morgan, Norbert Ndjeka, Tasnim Hasan, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network StudyHsin Yi Chen, Thomas Falconer, Anna Ostropolets, et al.
Diabetes, Obesity & Metabolism|June 3, 2026
Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network StudyHsin Yi Chen, Thomas Falconer, Anna Ostropolets, et al.
Vaccine|November 10, 2021
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, AustraliaSally F Gordon, Hazel J Clothier, Hannah Morgan, et al.
The American Journal of Dermatopathology|June 17, 2026
Assessing Nuclear and Nucleolar Areas Between Malignant Melanoma and Benign NeviCarol Stegura, Nolan Steevens, Hannah Neimy, et al.
JCI Insight|March 8, 2024
Macrophage-enriched Sectm1a promotes efficient efferocytosis to attenuate ischemia/reperfusion-induced cardiac injuryXiaohong Wang, Wa Du, Yutian Li, et al.
The Medical Journal of Australia|December 10, 2024
Clinical phenotype of COVID-19 vaccine-associated myocarditis in Victoria, 2021-22: a cross-sectional studyJulia Smith, Silja Schrader, Hannah Morgan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2023
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysisTasnim Hasan, Ellie Medcalf, Bern-Thomas Nyang'wa, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Dermatology|June 28, 2025
Are Skin Lesion Superclinics Associated With Decision Fatigue? A Controlled, Observational StudyHuw W S Greenish, Hafsa Faarax Shirwac, Hannah Morgan, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
The Role Of Drug Indication On Incidence Rate Heterogeneity: A Large-Scale, Systematic Evaluation Across An International Network Of Observational DatabasesHsin Yi Chen, Christopher Knoll, Elise Boventer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2024
Treatment of Multidrug-resistant or Rifampicin-resistant Tuberculosis With an All-oral 9-month Regimen Containing Linezolid or Ethionamide in South Africa: A Retrospective Cohort StudyHannah Morgan, Norbert Ndjeka, Tasnim Hasan, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network StudyHsin Yi Chen, Thomas Falconer, Anna Ostropolets, et al.
Diabetes, Obesity & Metabolism|June 3, 2026
Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network StudyHsin Yi Chen, Thomas Falconer, Anna Ostropolets, et al.
Vaccine|November 10, 2021
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, AustraliaSally F Gordon, Hazel J Clothier, Hannah Morgan, et al.
The American Journal of Dermatopathology|June 17, 2026
Assessing Nuclear and Nucleolar Areas Between Malignant Melanoma and Benign NeviCarol Stegura, Nolan Steevens, Hannah Neimy, et al.
JCI Insight|March 8, 2024
Macrophage-enriched Sectm1a promotes efficient efferocytosis to attenuate ischemia/reperfusion-induced cardiac injuryXiaohong Wang, Wa Du, Yutian Li, et al.
The Medical Journal of Australia|December 10, 2024
Clinical phenotype of COVID-19 vaccine-associated myocarditis in Victoria, 2021-22: a cross-sectional studyJulia Smith, Silja Schrader, Hannah Morgan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2023
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysisTasnim Hasan, Ellie Medcalf, Bern-Thomas Nyang'wa, et al.
Pageof 5